Key elements in the fight against ovarian cancer include access to molecular diagnostics, awareness of the presence of BRCA1 or BRCA2 gene mutations in the family, the use of effective treatment methods at an early stage of the disease, and improvement in the quality of comprehensive treatment. Here, BRCA2 is linked to ovarian cancer.